BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7534114)

  • 1. Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization.
    Kobayashi H; Rowley JD
    Genes Chromosomes Cancer; 1995 Jan; 12(1):66-9. PubMed ID: 7534114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
    Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
    Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.
    Sato Y; Suto Y; Pietenpol J; Golub TR; Gilliland DG; Davis EM; Le Beau MM; Roberts JM; Vogelstein B; Rowley JD
    Blood; 1995 Aug; 86(4):1525-33. PubMed ID: 7632960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations.
    Odero MD; Carlson K; Lahortiga I; Calasanz MJ; Rowley JD
    Cancer Genet Cytogenet; 2003 Apr; 142(2):115-9. PubMed ID: 12699886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies.
    Johansson B; Arheden K; Höglund M; Othzén A; Békássy AN; Turesson I; Heim S; Mitelman F
    Genes Chromosomes Cancer; 1995 Sep; 14(1):56-62. PubMed ID: 8527385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements.
    Andreasson P; Johansson B; Billström R; Garwicz S; Mitelman F; Höglund M
    Leukemia; 1998 Mar; 12(3):390-400. PubMed ID: 9529134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization.
    Kobayashi H; Espinosa R; Thirman MJ; Fernald AA; Shannon K; Diaz MO; Le Beau MM; Rowley JD
    Genes Chromosomes Cancer; 1993 Aug; 7(4):204-8. PubMed ID: 7692945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.
    Slater RM; von Drunen E; Kroes WG; Weghuis DO; van den Berg E; Smit EM; van der Does-van den Berg A; van Wering E; Hählen K; Carroll AJ; Raimondi SC; Beverloo HB
    Leukemia; 2001 Jun; 15(6):915-20. PubMed ID: 11417477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization.
    Tosi S; Giudici G; Rambaldi A; Scherer SW; Bray-Ward P; Dirscherl L; Biondi A; Kearney L
    Genes Chromosomes Cancer; 1999 Mar; 24(3):213-21. PubMed ID: 10451701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two unbalanced translocations, t(12;22)(p13;q11) and t(12;?)(p13;?), in an aggressive chronic B-cell leukemia: TEL gene analysis using FISH.
    Conchon M; McManus AP; Min T; Maljaie SH; Crawford A; Brito-Babapulle V; Matutes E; Catovsky D
    Cancer Genet Cytogenet; 1997 Jun; 95(2):137-40. PubMed ID: 9169030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).
    Tosi S; Harbott J; Haas OA; Douglas A; Hughes DM; Ross FM; Biondi A; Scherer SW; Kearney L
    Leukemia; 1996 Apr; 10(4):644-9. PubMed ID: 8618441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic characterization of rearrangements involving 12p in leukemia.
    Vieira L; Marques B; Cavaleiro C; Ambrósio AP; Jorge M; Neto A; Costa JM; Júnior EC; Boavida MG
    Cancer Genet Cytogenet; 2005 Mar; 157(2):134-9. PubMed ID: 15721634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2.
    Höglund M; Johansson B; Pedersen-Bjergaard J; Marynen P; Mitelman F
    Blood; 1996 Jan; 87(1):324-30. PubMed ID: 8547659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome abnormalities of the short arm of chromosome 12 in hematopoietic malignancies: a report including three novel translocations involving the TEL/ETV6 gene.
    Berger R; Le Coniat M; Lacronique V; Daniel MT; Lessard M; Berthou C; Marynen P; Bernard O
    Leukemia; 1997 Sep; 11(9):1400-3. PubMed ID: 9305591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12p rearrangement and DNA amplification mapped by comparative genomic hybridization in a patient with secondary myeloid leukemia.
    Willem P; Mendelow B
    Cancer Genet Cytogenet; 1997 Nov; 99(1):30-7. PubMed ID: 9352793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies.
    Wlodarska I; Marynen P; La Starza R; Mecucci C; Van den Berghe H
    Cytogenet Cell Genet; 1996; 72(2-3):229-35. PubMed ID: 8978784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome derived from translocation(1;17) retains alphoid sequences of both chromosomes involved.
    Fugazza G; Bruzzone R; Sessarego M
    Cancer Genet Cytogenet; 1994 Nov; 78(1):7-9. PubMed ID: 7987809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of myeloid disorders and a t(8;12) (q12;p13).
    Hernández JM; González MB; García JL; Ferro MT; Gutiérrez NC; Marynen P; San Miguel JF
    Haematologica; 2000 Jan; 85(1):31-4. PubMed ID: 10629588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of pericentric inversion 12, inv(12)(p13.1q11), by fluorescence in situ hybridization in a patient with acute myeloid leukemia (AML-M6).
    Sato Y; Bohlander SK; Kobayashi H; Suto Y; Davis EM; Espinosa R; Le Beau MM; Rowley JD
    Cancer Genet Cytogenet; 1997 Sep; 97(2):157-60. PubMed ID: 9283600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subtle deletion of 12p by routine cytogenetics is found to be a translocation to 21q by fluorescence in situ hybridization: t(12;21)(p13;q22).
    Filatov LV; Saito M; Behm FG; Rivera GK; Raimondi SC
    Cancer Genet Cytogenet; 1996 Jul; 89(2):136-40. PubMed ID: 8697420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.